Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | EVP and CCO | April 22, 2020 | April 24, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date April 22, 2020 · Filed April 24, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 55,584 |
Ending reported balance
After 2020-04-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-04-22 · Grant · Acquired 19,893 · Balance 62,397 F1: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals. Row 2 · 2020-04-22 · Tax withholding · Disposed 6,813 · Balance 55,584 F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 22, 2020 Filed Apr 24, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 6,813 | $1.96 | $13,353.48 |
DisclosureSEC source: 0001127602-20-014492 · form4.xml · nonDerivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,584 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 19,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014492 · form4.xml · nonDerivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,397 F1 · kind: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 22,853 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · derivative · entry 9 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,707 Underlying: Common Stock · 22,853 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,464 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · derivative · entry 8 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,463 Underlying: Common Stock · 8,464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · derivative · entry 7 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,592 Underlying: Common Stock · 2,593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · derivative · entry 6 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 12,420 | $2.77 | $34,403.40 |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · nonDerivative · entry 5 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,504 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 22,853 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · nonDerivative · entry 4 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,464 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · nonDerivative · entry 3 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · nonDerivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008965 · form4.xml · nonDerivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 211,690 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001127602-20-004597 · form4.xml · derivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,690 Underlying: Common Stock · 211,690 shares Expires 2030-02-06 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 70,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004597 · form4.xml · derivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,560 Underlying: Common Stock · 70,560 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| September 18, 2019 Filed Sep 19, 2019 20:26 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 2,000 | $3.52 | $7,040.00 |
DisclosureSEC source: 0001127602-19-028812 · form4.xml · nonDerivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,661 Read SEC document |
| September 18, 2019 Filed Sep 19, 2019 20:26 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 2,500 | $3.23 | $8,075.00 |
DisclosureSEC source: 0001127602-19-028812 · form4.xml · nonDerivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,661 Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009264 · form4.xml · derivative · entry 7 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,927 Underlying: Common Stock · 8,463 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009264 · form4.xml · derivative · entry 6 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,185 Underlying: Common Stock · 2,593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009264 · form4.xml · derivative · entry 5 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 Underlying: Common Stock · 2,352 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 4,544 | $5.51 | $25,037.44 |
DisclosureSEC source: 0001127602-19-009264 · form4.xml · nonDerivative · entry 4 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,161 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009264 · form4.xml · nonDerivative · entry 3 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009264 · form4.xml · nonDerivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009264 · form4.xml · nonDerivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 23:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 68,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004888 · form4.xml · derivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,560 Underlying: Common Stock · 68,560 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 23:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 127,320 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0001127602-19-004888 · form4.xml · derivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,320 Underlying: Common Stock · 127,320 shares Expires 2029-02-07 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/7/2020) and vests 1/48th per month for each month of service thereafter Read SEC document |
| May 23, 2018 Filed May 25, 2018 20:43 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 745 | $9.78 | $7,286.10 |
DisclosureSEC source: 0001127602-18-018984 · form4.xml · nonDerivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,297 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:09 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009731 · form4.xml · derivative · entry 5 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,778 Underlying: Common Stock · 2,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:09 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009731 · form4.xml · derivative · entry 4 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,705 Underlying: Common Stock · 2,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:09 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 1,652 | $8.53 | $14,091.56 |
DisclosureSEC source: 0001127602-18-009731 · form4.xml · nonDerivative · entry 3 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,552 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:09 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009731 · form4.xml · nonDerivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:09 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009731 · form4.xml · nonDerivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 22:14 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 71,940 | $0.00 Strike: $9.79 | $0.00 |
DisclosureSEC source: 0001127602-18-005204 · form4.xml · derivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,940 Underlying: Common Stock · 71,940 shares Expires 2028-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2019) and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 22:14 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 25,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005204 · form4.xml · derivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,390 Underlying: Common Stock · 25,390 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F2 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 2,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009396 · form4.xml · derivative · entry 3 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,058 Underlying: Common Stock · 2,352 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 1,093 | $16.45 | $17,979.85 |
DisclosureSEC source: 0001127602-17-009396 · form4.xml · nonDerivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,259 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009396 · form4.xml · nonDerivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units (Phantom Stock) · Derivative | 10,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005425 · form4.xml · derivative · entry 2 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,370 Underlying: Common Stock · 10,370 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 41,470 | $0.00 Strike: $14.44 | $0.00 |
DisclosureSEC source: 0001127602-17-005425 · form4.xml · derivative · entry 1 Santini Alexander A · CIK 0001690619 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,470 Underlying: Common Stock · 41,470 shares Expires 2027-02-09 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/9/2018) and vests 1/48th per month for each month of service thereafter Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.